Evidence map›Paper›PMID 33661977›Full record

ArticlePloS one2021

Flow Assisted Mutation Enrichment (FAME): A highly efficacious and efficient method to enrich Double Knockouts (DKO) after gene editing.

Michael Hansen, Xiaopin Cai, Sara Bowen, David A Largaespada, Ming V Li

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Enrichment strategies to enhance genome editing.Journal of biomedical science · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Michael HansenDivision of Endocrinology, Phoenix VA Medical Center, Phoenix, Arizona, United States of America.
Xiaopin CaiDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, United States of America.
Sara BowenFlow Cytometry Core Facility, Barrow Neurological Institute, Phoenix, Arizona, United States of America.
David A LargaespadaDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, United States of America.
Ming V LiDivision of Endocrinology, Phoenix VA Medical Center, Phoenix, Arizona, United States of America.ORCID 0000-0003-3740-5354
University of Minnesota · USBarrow Neurological Institute · USPhoenix VA Health Care System · USUniversity of Arizona · US

Funding

Searching for Genetic Basis for Metastasis of Differentiated Thyroid CancerR21CA201735 · NCI · UNIVERSITY OF MINNESOTA · PI LARGAESPADA, DAVID ANDREW · 2016 to 2017
$355k
NCI NIH HHS R21 CA201735
6 · The paper itself

Abstract

Gene editing has become an essential tool for interrogation of gene function in biomedical research and is also a promising approach for gene therapy. Despite recent progresses, the gene-editing procedure is still a tedious process involving manually isolating large number of single cell colonies to screen for desired mutations. For diploid eukaryotic cells, there is the additional challenge to inactivate both alleles for genes-of-interest, i.e., generating double knockouts (DKOs), for the desired phenotypes or therapeutic effects. In this report, we present a novel method based on Fluorescence Assisted Cell Sorting (FACS) to enrich for DKO cells, using a cell surface marker β2-microglobulin (B2M) as a basis for negative selection. This method significantly increased percentage of DKOs in isolated cells after gene editing, and in the meantime, significantly improve the efficiency of workflow by automating colony isolation. It would greatly facilitate future biomedical research including potential gene/cell therapies.

Indexed as

Flow CytometryGene EditingGene Knockout TechniquesHEK293 CellsHumans

Identifiers

PMID33661977
PMCPMC7932066
OpenAlexW3133963482

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.